Share this

Cancer Studies

The Cancer Network supports studies which are funded by an NHS Research Scotland Eligible Funder list. All Scottish research ongoing within the network is registered on the UK Clinical Research Network portfolio database. In collaboration with our partner organisations we are involved in a wide variety of cancer research. The aim of our research is to help us understand cancer better and to help our patients effected by the disease.

The research we undertake is done in many different forms, for example:

  • Bench Work: This is done within the laboratories of CRUK, HGU, ECMC and the MRC. It looks at a portfolio of investigations including genetic patterns, drug development and DNA profiling.
  • Translation research: This is research which looks at patient samples (often tissue from surgery or blood samples) to improve our understanding of cancer. This can include looking at genes which may cause cancers, factors that can predict how patients may respond to treatments as well as a variety of other research.
  • Clinical Studies: These studies help us evaluate treatments such as new drugs or radiotherapy regimens to ensure they are safe and that they improve outcomes for patients. New drugs go through strict testing in the laboratory before they are offered to patients. After the laboratory testing there are 3 main phases of clinical studies. Each phase has a different purpose:
    • Phase 1 studies involve small numbers of patients and aim to establish a safe dose for the drug and identify any possible side effects.
    • Phase 2 studies involve larger numbers of patients and look at different ways of delivering the treatment, whether the new delivery proves effective and what dose and frequency to use.
    • Phase 3 studies involve large numbers of patients. These studies compare new treatment against the best available current treatment to see which is most effective against cancer.
    • Other Studies: Other clinical studies may look at new ways of preventing, diagnosing and screening cancer or cancer related side effects such as pain or fatigue.

If you would like to find out more about our portfolio or are interested in recruiting to any of our studies please contact:

Scottish Cancer Research Network - West

NHS Ayrshire and Arran, NHS Greater Glasgow and Clyde, NHS Forth Valley and NHS Lanarkshire

Karen Bell:

Scottish Cancer Research Network – South East

NHS Borders, NHS Dumfries and Galloway, NHS Fife and NHS Lothian

Dorothy Boyle:

Scottish Cancer Research Network – North

NHS Grampian, NHS Highland, NHS Orkney, NHS Shetland, NHS Western Isles

Kirsty Shearer:

Scottish Cancer Research Network – East

NHS Tayside

Kirsty Shearer: